Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02568943
Title An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple Myeloma
Recruitment No longer available
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries DEU | CAN | AUT

Facility Status City State Zip Country Details
Novartis Investigative Site Innsbruck Tyrol 6020 Austria Details
Novartis Investigative Site Linz A-4010 Austria Details
Novartis Investigative Site Rankweil A-6830 Austria Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Vienna A-1090 Austria Details
Novartis Investigative Site Wien 1140 Austria Details
Novartis Investigative Site Kitchener Ontario N2G 1G3 Canada Details
Novartis Investigative Site Montreal Quebec H4J 1C5 Canada Details
Novartis Investigative Site Saskatoon Saskatchewan S7N 4H4 Canada Details
Novartis Investigative Site Mannheim Baden-Wuerttemberg 68305 Germany Details
Novartis Investigative Site Bad Saarow 15526 Germany Details
Novartis Investigative Site Bamberg 96049 Germany Details
Novartis Investigative Site Bayreuth 95445 Germany Details
Novartis Investigative Site Bielefeld 33604 Germany Details
Novartis Investigative Site Bonn 53105 Germany Details
Novartis Investigative Site Bremen 28177 Germany Details
Novartis Investigative Site Chemnitz 09113 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Greifswald 17475 Germany Details
Novartis Investigative Site Hamburg 22763 Germany Details
Novartis Investigative Site Hannover 30449 Germany Details
Novartis Investigative Site Heidelberg 69120 Germany Details
Novartis Investigative Site Jena 07740 Germany Details
Novartis Investigative Site Karlsruhe 76133 Germany Details
Novartis Investigative Site Kiel 24105 Germany Details
Novartis Investigative Site Magdeburg 39120 Germany Details
Novartis Investigative Site Mainz 55131 Germany Details
Novartis Investigative Site Muenchen 81737 Germany Details
Novartis Investigative Site Mutlangen 73557 Germany Details
Novartis Investigative Site Nuernberg 90419 Germany Details
Novartis Investigative Site Rostock 18057 Germany Details
Novartis Investigative Site Tübingen 72076 Germany Details
Novartis Investigative Site Winnenden 71364 Germany Details
Novartis Investigative Site Wuerzburg 97080 Germany Details
Novartis Investigative Site Amman 11941 Jordan Details
Novartis Investigative Site Oslo NO-0424 Norway Details
Novartis Investigative Site Trondheim 7006 Norway Details
Novartis Investigative Site Linkoping SE 581 85 Sweden Details
Novartis Investigative Site Stockholm 14186 Sweden Details
Novartis Investigative Site Umea 901 85 Sweden Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field